RecruitingNCT06797934
Establishment of a Registry of Patients With Parathyroid Disease
Sponsor
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Enrollment
1,200 participants
Start Date
Jan 3, 2022
Study Type
OBSERVATIONAL
Conditions
Summary
Establishment of a registry with which to census all patients under the care of the O.U. Endocrinology for parathyroid pathology in order to longitudinally evaluate biochemical, clinical, radiological, medico-nuclear and histological data in future studies.
Eligibility
Min Age: 18 Years
Inclusion Criteria3
- Age ≥18 years
- Diagnosis of hyperparathyroidism or hypoparathyroidism based on biochemical parameters (calcemia, parathormone, phosphormia, creatinine, albumin, vitamin D25OH)
- Obtaining informed consent
Exclusion Criteria1
- none
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06797934
Related Trials
A Study to Test the Effects and Safety of Palopegteriparatide in Adolescents With Long-term Hypoparathyroidism
NCT077067641 location
A Study to Investigate Canvuparatide Compared With Placebo in Adult Patients With Hypoparathyroidism
NCT076994712 locations
Parathyroidectomy After Kidney Transplantation
NCT074154211 location
Efficacy and Safety of XH02 for the Treatment of Hypoparathyroidism
NCT071974501 location
A Cohort Study on the Safety and Efficacy of XH-02 in Treating Hypoparathyroidism
NCT075402861 location